Related references
Note: Only part of the references are listed.Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome
I. Marie et al.
AUTOIMMUNITY REVIEWS (2012)
The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy
Boel De Paepe et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Anti-PL-7 (Anti-Threonyl-tRNA Synthetase) Antisynthetase Syndrome Clinical Manifestations in a Series of Patients From a European Multicenter Study (EUMYONET) and Review of the Literature
Ane Labirua-Iturburu et al.
MEDICINE (2012)
Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab
Jin-Kyoung Park et al.
RHEUMATOLOGY INTERNATIONAL (2012)
High Frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis
Ayako Nakajima et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Juvenile dermatomyositis: new insights and new treatment strategies
Neil Martin et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Tolerability and Safety of Biological Therapies for Psoriasis in Daily Clinical Practice: A Study of 103 Italian Patients
Alexandra Maria Giovanna Brunasso et al.
ACTA DERMATO-VENEREOLOGICA (2011)
A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group
Anthony A. Amato et al.
ANNALS OF NEUROLOGY (2011)
Etanercept as Steroid-Sparing Agent in Dermatomyositis
Alexandra Maria Giovanna Brunasso et al.
ANNALS OF NEUROLOGY (2011)
Double Trouble Therapeutic Challenges in Patients With Both Juvenile Dermatomyositis and Psoriasis
Nikki N. Kim et al.
ARCHIVES OF DERMATOLOGY (2011)
Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF-α therapy?
Alexandra Maria Giovanna Brunasso et al.
CLINICAL RHEUMATOLOGY (2011)
A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
Yuki Ishikawa et al.
CLINICAL RHEUMATOLOGY (2011)
Myositis-related interstitial lung disease and antisynthetase syndrome
Joshua Solomon et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2011)
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies
C. Cappelletti et al.
NEUROLOGY (2011)
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review
Andreas V. Hadjinicolaou et al.
RHEUMATOLOGY (2011)
Development of antisynthetase syndrome in a patient with rheumatoid arthritis
Cheol-Kyu Park et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Antisynthetase syndrome associated with long-standing rheumatoid arthritis
Takao Nagashima et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases
Roberto Perez-Alvarez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Paradoxical Reactions to Targeted Biological Treatments: A Way to Treat and Trigger?
Alexandra M. G. Brunasso et al.
ACTA DERMATO-VENEREOLOGICA (2010)
Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis
Rachel Klein et al.
ARCHIVES OF DERMATOLOGY (2010)
Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis
Margo J. Bendewald et al.
ARCHIVES OF DERMATOLOGY (2010)
Antisynthetase Syndrome Presenting as Rheumatoid-Like Polyarthritis
Gregory E. Mumm et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2010)
Anticyclic Citrullinated Peptide Antibodies as Markers of Erosive Arthritis in Antisynthetase Syndrome
Lorenzo Cavagna et al.
JOURNAL OF RHEUMATOLOGY (2010)
Dermatomyositis During Adalimumab Therapy for Rheumatoid Arthritis
Alexandra Maria Giovanna Brunasso et al.
JOURNAL OF RHEUMATOLOGY (2010)
Destructive Arthropathy Associated with Dermatomyositis Sine Myositis Positive for Anti-Jo-1 and Anti-Cyclic Citrullinated Peptide Antibodies
Takao Nagashima et al.
JOURNAL OF RHEUMATOLOGY (2009)
Thrombocytopenia associated with the use of anti-tumor necrosis factor-α agents for psoriasis
Alexandra Maria Giovanna Brunasso et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis
Kyoung-Hwa Choi et al.
RHEUMATOLOGY INTERNATIONAL (2009)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Autoimmune diseases induced by TNF-targeted therapies
Manuel Ramos-Casals et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis
P. Riley et al.
RHEUMATOLOGY (2008)
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis
Ronan J. Walsh et al.
ARTHRITIS AND RHEUMATISM (2007)
Inflammatory molecules: A target for treatment of systemic autoimmune diseases
A. Tincani et al.
AUTOIMMUNITY REVIEWS (2007)
Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma
E. Liozon et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies
Maija-Leena Eloranta et al.
ARTHRITIS AND RHEUMATISM (2007)
Tumour necrosis factor-α single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies
H. Chinoy et al.
RHEUMATOLOGY (2007)
Treatment of early and refractory dermatomyositis with infliximab: a report of two cases
Sylvia Dold et al.
CLINICAL RHEUMATOLOGY (2007)
Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions
Gillian C. de Gannes et al.
ARCHIVES OF DERMATOLOGY (2007)
Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor
Harald A. Hall et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
P. Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
M De Bandt et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Refractory polymyositis responding to infliximab
I Uthman et al.
RHEUMATOLOGY (2004)
Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab
A Selva-O'Callaghan et al.
RHEUMATOLOGY (2004)
Case report:: successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha
C Korkmaz et al.
RHEUMATOLOGY (2004)
Polymyositis associated with infliximab treatment for rheumatoid arthritis
J Musial et al.
RHEUMATOLOGY (2003)
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations
GJD Hengstman et al.
EUROPEAN NEUROLOGY (2003)
Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab
E Roddy et al.
RHEUMATOLOGY (2002)
Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNFα-308A allele in children with juvenile dermatomyositis
J Lutz et al.
CLINICAL IMMUNOLOGY (2002)
Association of polymyositis with rheumatoid arthritis
E Martínez-Cordero et al.
RHEUMATOLOGY INTERNATIONAL (2001)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
Share Paper
